pharmaphorum March 25, 2022
Eliane Boucher

In January, PLOS Digital Health published a study which claimed that there’s “sparse” data to support the efficacy of most mental health apps.

In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. Without digging further, one might think the current case for digital therapeutics is weak.

I reviewed all 14 meta-analyses included in the study and found the analysis to be accurate, but incomplete.

These analyses focused exclusively on wellness and smoking cessation apps, bypassing a category of digital therapeutics regulated by the FDA that make scientifically validated claims using sound research.

The Missing Context: Wellness Apps vs. Digital Therapeutics

There are approximately 20,000 mental...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Apps, Digital Health, Mental Health, Provider, Survey / Study, Technology, Trends
Unhinged: The Virtual MSK Reckoning (and What Comes Next)
Screenagers to Silver Surfers: How each generation clicks with care
Digital Health Rewired 2025: 10 Key Talking Points
New Law Extends Telehealth Flexibilities Another 6 Months
Better Science, Better Medicine: How Clinical Research Advances Women’s Health

Share This Article